DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.
Financial Statements
- Click here to download Dexcom Inc's Income Statement
- Click here to download Dexcom Inc's Balance Sheet
- Click here to download Dexcom Inc's Statement of Cash Flows
Key Info
- Industry: Surgical and Medical Instrument Manufacturing
- Sector: Manufacturing
- CEO Name: Kevin Sayer
Key Statistics
- Stock Price: $529.42
- Dividend Yield: 0%
- Market Capitalization: $50,458,421,828
- Shares Outstanding: 96,748,901
- Number of Employees: 5,500
- Trailing 12-Month EPS: $5.33
- Trailing 12-Month DPS: $0
- Payout Ratio: 0.0%
Important Dates
- Next Earnings Date: 2021-10-27
- Next Ex-Dividend Date:
Price Trends
- Current Stock Price: $529.42
- 52-week high: $528.3
- 52-week low: $305.63
- 200-day moving average: $410.91
- 50-day moving average: $488.17
Performance
- 1-Month Price Return: 1.2%
- 3-Month Price Return: 41.2%
- 6-Month Price Return: 31.1%
- 1-Year Price Return: 24.5%
- 2-Year Price Return: 203.9%
- 5-Year Price Return: 466.1%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast